The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
SARCLISA isatuximab 100 mg/5 mL concentrated injection vial (2023-24)
Product name
SARCLISA isatuximab 100 mg/5 mL concentrated injection vial
Sponsor name
Sanofi-Aventis Australia Pty Ltd
Year Range
2023-24